Literature DB >> 6332093

Evaluation of various cytostatic drugs as local immunotherapeutic agents.

R J Scheper, A Vos, J de Groot, G H Boerrigter.   

Abstract

The cytostatic drugs methotrexate, 5-fluorouracil, adriamycin, vincristin, cisplatinum, VP-16 and the newly synthesized, stabile cyclophosphamide-derivative Z-7557, were screened for possible immunopotentiating effects in local chemotherapy. With an in vivo contact sensitivity model in guinea pigs, low dosages of the drugs were introduced into antigenically stimulated lymph nodes by intradermal injections following sensitization. Marked till strong potentiation of T-cell function, as measured by the development of contact hypersensitivity, was observed with all drugs tested, except for methotrexate and 5-fluorouracil. With a similar local chemotherapeutic protocol in the guinea pig line 10 hepatocellular carcinoma-model, these latter drugs have been reported earlier to be exceptional in failing to induce tumor regression and tumor immunity. Our present results suggest that local chemotherapy of malignancies not only may reduce local tumor load, but also may affect distant metastases by facilitating the development of tumor-specific immunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332093     DOI: 10.1007/bf00232355

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  25 in total

1.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

2.  Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  H K Gill; F Y Liew
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

Review 3.  Immunological aspects of contact sensitivity.

Authors:  L Polak
Journal:  Monogr Allergy       Date:  1980

4.  Augmentation of the human immune response by cyclophosphamide.

Authors:  D Berd; M J Mastrangelo; P F Engstrom; A Paul; H Maguire
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

5.  Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs.

Authors:  J Bier; H Bier; S Kleinschuster; H Rapp
Journal:  Head Neck Surg       Date:  1982 Jul-Aug

6.  Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.

Authors:  S Shu; P A Steerenberg; J T Hunter; C H Evans; H J Rapp
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

Review 7.  Effect of cyclophosphamide on immunological control mechanisms.

Authors:  J L Turk; D Parker
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

8.  Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.

Authors:  M Glaser
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

Authors:  R J North
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.

Authors:  M Goto; A Mitsuoka; M Sugiyama; M Kitano
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  5 in total

1.  Synergistic effects of locally administered cytostatic drugs and a surfactant on the development of delayed-type hypersensitivity to keyhole limpet haemocyanin in mice.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.

Authors:  A M Claessen; H Valster; H Bril; S Meyer; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.

Authors:  J Limpens; M Van Meijer; H M Van Santen; W T Germeraad; K Hoeben-Schornagel; M Breel; R J Scheper; G Kraal
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

4.  Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

5.  Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine.

Authors:  Eduardo Lasalvia-Prisco; Emilio Garcia-Giralt; Silvia Cucchi; Jesús Vázquez; Leonard Robinson; John Dalton
Journal:  Biologics       Date:  2007-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.